Primun non nocere
Primun non nocere
Barra lateral del artículo
PDF
FLIP
Contenido principal del artículo
Descargas
Detalles del artículo
Referencias (VER)
(1) Del Río L, Soto SC, Camargo M, Sánchez R, Mancilla CL, Patarroyo ME, et al. The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents. PLoS ONE. 2016; 11(11): e0166502. doi:10.1371/journal.pone.0166502 DOI: https://doi.org/10.1371/journal.pone.0166502
(2) Pimenta J, Borges I. Efficacy of the Vaccines against Human Papillomavirus in Women Older than 24 Years in the Cervix Cancer Prevention. Acta Med Port. 2016; 29(6): 401-408. doi: 10.20344/amp.7095. Epub 2016 Jun 30.
(3) Francis T. Evaluation of the 1954 Poliomyelitis Vaccine Field Trialfurther Studies of Results Determining the Effectiveness of Poliomyelitis Vaccine (Salk) in Preventing Paralytic Poliomyelitis. JAMA. 1955; 158(14):1266-1270. doi:10.1001/jama.1955.02960140028004 DOI: https://doi.org/10.1001/jama.1955.02960140028004
(4) Centers for Disease Control and Prevention (CDC). Withdrawal of Rotavirus Vaccine Recommendation. MMWR Morb Mortal Wkly Rep 1999; 48:1007.
Citaciones
